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We have investigated the eﬀects of WY14643, a potent peroxisome proliferator activator receptor-α (PPAR-α) agonist, in a rat
model of ligature-induced periodontitis. Male Sprague-Dawley rats were lightly anaesthetized with pentobarbitone (35mg/kg).
Sterile, 2-0 black braided silk thread was placed around the cervix of the lower left ﬁrst molar and knotted medially. Animals
received WY14643 (1mg/kg i.p, daily for eight days). Eighths days after placement of the ligature, we evaluated several markers
of inﬂammation such us (1) myeloperoxidase activity, (2) a cytokines and adhesion molecules expression, (3) NF-κB expression,
(4) iNOS expression, (5) the nitration of tyrosine residues, (6) activation of the nuclear enzyme poly(ADP-ribose) polymerase,
(7) apoptosis, and (8) the degree of gingivomucosal tissues injury. Administration of WY14643 signiﬁcantly decreased all of the
parameters of inﬂammation as described above. These results demonstrate that WY14643 exerts an anti-inﬂammatory role during
experimental periodontitis and is able to ameliorate the tissue damage.
1.Introduction
Periodontitis is an inﬂammatory lesion, mediated by accu-
mulationofbacteriathatleadstothelossofconnectivetissue
attachment to root surface cementum and adjacent alveolar
bone resulting in tooth loss [1] .S t u d i e sh a v ed e m o n s t r a t e d
that periodontal disease aﬀects between 10% and 15%
of the world’s population [2]. The exact mechanism of
periodontitis development, including the prior agents or
mediators involved, is not clear. Periodontitis manifests itself
as a multifactor phenomenon. It is now clear that, while
the etiology of periodontitis is bacteria, the pathogenesis is
inﬂammatory.
Itiswidelyacceptedthattheinitiationandprogressionof
periodontitis are dependent upon the presence of microor-
ganisms capable of causing disease. Although more than
500–600 species of microorganisms have been isolated from
periodontal pockets [3], it is likely that only a small percent-
age of these are etiologic agents [4]. In addition to the pos-
sible direct pathologic eﬀects of bacteria on the periodontal
tissues, it is clear that damage to the periodontium must also
occur by indirect means. Bacterial products must gain access
to the cellular constituents of the gingival tissues and activate
cellular processes that are destructive to collagenous connec-
tive tissue and bone [5]. Then, Periodontitis is seen as the
directconsequenceofbacterialinvasionandisregardedasan
infectious disease. Recently, however, there arises a question
but, microorganisms are the initiators of periodontal disease
or are the result? Hasturk et al. in a study of experimental
periodontitis, showed that the pharmacological control of
the inﬂammatory process has resulted in the disappearance
of the oﬀending organism as an initiator of the disease [6].2 PPAR Research
In this study, we therefore wanted to study whether the
modulation of the inﬂammatory process could limit the
development of periodontitis. Peroxisome proliferator-acti-
vated receptors (PPARs) are a family of nuclear receptors
comprising three isoforms, PPARα,P P A R δ,a n dP P A R γ,
which act as ligand-activated transcriptional factors. PPARs
play key roles in energy homeostasis by modulating glucose
and lipid metabolism and transport. PPARα is also critical
in inﬂammation and is the molecular target of the ﬁbrates
c l a s so fd r u g s ,s u c ha sf e n o ﬁ b r a t e ,w h i c ha c ta sa g o n i s t i c
ligandsofPPAR-α[7].IthasbeenshownthatPPAR-αligands
regulates inﬂammatory responses [8]. In particular, it has
beenreportedthatPPAR-αligandscaninhibit theexpression
ofvariousproinﬂammatorygenes,suchasinterleukin(IL)-6,
vascular cell adhesion molecule-1, platelet-activating factor
(PAF) receptor and cyclooxygenase (COX)-2 (generating
PGE2 and TxB2), in response to cytokine activation [9,
10]. This may, in part, be dependent on the inhibition of
functional nuclear factor (NF)-κB activation and on the
increase of expression of the inhibitory protein IκBα [11].
The present study was carried out in order to gain a better
understanding of the possible inﬂuence of PPAR-α in a
mouse model of periodontitis.
2. Methods
2.1. Surgical Procedure. Male Sprague Dawley rats (280–
400g) were lightly anaesthetized with surgical doses of
sodium pentobarbitone (35mg/kg). Sterile, 2-0 black brai-
ded silk thread was placed around the cervix of the lower
left ﬁrst molar and knotted medially as previously described
[12]. After the rats had recovered from the anaesthetic they
were allowed to eat commercial laboratory food and drink
tap water ad libitum. Animal care and protocol was in
compliance with Italian regulations on protection of animals
used for experimental and other scientiﬁc purpose (D.M.
116192) as well as with the EEC regulations (O.J. of E.C.
L 358/1 12/18/1986). The animals and the study protocol
were approved by the Institutional Animal Care and User
Committee of the University of Messina.
2.2. Experimental Groups. Rats were randomly allocated into
the following groups.
(i) Ligature + vehicle group:r a t sw e r es u b j e c t e dt o
ligature-induced periodontitis and animals received
vehicle i.p. (1h after the ligature placement and daily
treatment for eight days).
(ii) Ligature + WY14643 group:r a t sw e r es u b j e c t e dt o
ligature-induced periodontitis and animals received
WY14643 (1mg/kg i.p., 1h after the ligature place-
ment and daily for eight days).
At 8 days after the ligature induction of periodontitis the rats
(N = 10fromeachgroupforeachparameter)weresacriﬁced
in order to assess the eﬀects of the compound on an acute
lesion. The right side that is not subject to ligature, was used
as control.
The dose of WY14643 was chosen on the basis of pre-
vious studies [13].
2.3. Histological Examination. For histopathological exam-
ination, biopsies of gingiva and mucosa tissue from the
buccal and lingual aspect of the teeth were taken 8 days
after the ligature induction of periodontitis. The tissue
slices were ﬁxed in 10% neutral-buﬀered formaldehyde
for 5 days, embedded in paraﬃn, and sectioned. The
sections, orientated longitudinally from the teeth crowns,
were stained with trichrome and haematoxylin eosin stains.
In the gingivomucosal sections stained with trichrome stain
the total number of inﬁltrating leukocytes (e.g., neutrophils
and mononuclear cells) in cortical interstitial spaces from
gingiva and mucosa tissues was assessed quantitatively by
counting the number of inﬁltrating leukocytes in 20 high
power ﬁelds.
2.4. Radiography. Mandibles were placed on a radiographic
box at a distance of 90cm from the X-ray source. Radio-
graphic analysis of normal and ligated mandibles was
performed by X-ray machine (Philips X12 Germany) with
a 40kW exposure for 0.01sec. A radiographic examination
of at eight day after ligature placement revealed bone matrix
resorption in the lower ﬁrst left after ligation as previously
described [12].
2.5. Myeloperoxidase Activity. Myeloperoxidase activity, an
indicator of polymorphonuclear leukocyte (PMN) accu-
mulation, was determined as previously described [14].
Gingivomucosal tissue, collected at the speciﬁed time,
were homogenized in a solution containing 0.5% hexa-
decyl-trimethyl-ammonium bromide dissolved in 10mM
potassium phosphate buﬀer (pH 7) and centrifuged for
30min at 20,000 × ga t4 ◦C. An aliquot of the supernatant
was then allowed to react with a solution of tetramethyl-
benzidine(1.6mM)and0.1mMH2O2.Therat eofc hangein
absorbancewasmeasuredspectrophotometricallyat650nm.
Myeloperoxidase activity was deﬁned as the quantity of
enzyme degrading 1μmol/min of peroxide at 37◦Ca n dw a s
expressed in milliunits/g of wet tissue.
2.6. Immunohistochemical Localization of iNOS, TNF-α,I L -
1β, ICAM-1, Nitrotyrosine, PAR, Bax, and Bcl-2. At 8 days
after the ligature induction of periodontitis, the gingivo-
mucosal tissues were ﬁxed in 10% buﬀered formaldehyde
and 8μm sections were prepared from paraﬃne m b e d d e d
tissues. After deparaﬃnization, endogenous peroxidase was
quenched with 0.3% H2O2 in 60% methanol for 30min.
The sections were permeabilized with 0.1% Triton X-100
in PBS for 20min. Nonspeciﬁc adsorption was minimized
by incubating the section in 2% normal goat serum in
phosphate buﬀered saline for 20min. Endogenous biotin or
avidin binding sites were blocked by sequential incubation
for 15min with avidin and biotin. The sections were
then incubated overnight with primary antiiNOS antibody
(Santa Cruz Biotechnology, 1:500 in PBS, v/v), antiICAM-
1 antibody (BD Pharmingen, CD54, 1:500), antinitroty-
rosine rabbit polyclonal antibody (1:500 in PBS, v/v),
antipoly(ADP-ribose) goat, an indicator of PARP activation,
(PAR; 1:500 in PBS, v/v) (Alexis; DBA, Milan, Italy) antiBaxPPAR Research 3
polyclonal antibody (Santa Cruz Biotechnology, 1:500 in
PBS, v/v),with antiBcl-2 polyclonal antibody (Santa Cruz
Biotechnology),antiTNF-αpolyclonalantibody(SantaCruz
Biotechnology, 1:500 in PBS, v/v), anti IL-1β polyclonal
antibody (Santa Cruz Biotechnology, 1:500 in PBS, v/v)
or with control solutions. Controls included buﬀer alone
or nonspeciﬁc puriﬁed rabbit IgG. Speciﬁc labeling was
detected with a biotin-conjugated goat antirabbit IgG and
avidin-biotin peroxidase complex (DBA, Milan, Italy). The
counter stain was developed with DAB (brown color) and
nuclear fast red (red background). A positive staining
(brown color) was found in the sections, indicating that
the immunoreactions were positive, no positive staining
(pink color) was observed in the sections indicating that
the immunoreactions were negative. Immunocytochemistry
photographs (N = 5) were assessed by densitometry as by
using Optilab Graftek software on a Macintosh personal
computer.
2.7. Western Blot Analysis for IkB-α, iNOS and Caspase-
3. In brief, gingivomucosal tissues from each rat were
suspended in extraction buﬀer A containing 0.2mM phenyl-
methylsulfonylﬂuoride(PMSF),0.15μMpepstatinA,20μM
leupeptin, and 1μM sodium orthovanadate; homogenized
at the highest setting for 2min; and centrifuged at 1000g
for 10min at 4◦C. Supernatants represented the cytoso-
lic fraction. The pellets, containing enriched nuclei, were
resuspended in buﬀer B containing 1% Triton X-100,
150mMNaCl, 10mMTris-HCl, pH 7.4, 1mMEGTA, 1mM
EDTA, 0.2mM PMSF, 20 M leupeptin, and 0.2mM sodium
orthovanadate. After centrifugation at 15,000g for 30min at
4◦C, the supernatants containing the nuclear protein were
stored at −80◦C for further analysis. Protein concentration
was determined with the Bradford-based kits (Bio-Rad,
Milan, Italy). The levels of IkB-α, iNOS and caspase-3 were
quantiﬁed in cytosolic fraction. The ﬁlters were blocked
with 1 xPBS, 5% (w/v) nonfat dried milk for 40min at
room temperature, and they were subsequently probed with
speciﬁc antibodies IkB-α (1:1000; Santa Cruz Biotechnol-
ogy, Inc.), antiiNOS (1:500; Santa Cruz Biotechnology,
Inc.), anticaspase-3 (Cell Signaling, 1:500), in 1 xPBS,
5% (w/v) nonfat dried milk, and 0.1% Tween 20 at 4◦C
overnight. Membranes were incubated with peroxidase-
conjugated bovine antimouse IgG secondary antibody or
peroxidase-conjugated goat antirabbit IgG (1:2000; Jackson
Immuno Research Laboratories Inc., West Grove, PA, USA)
for 1h at room temperature. The relative expression of
the protein bands of IkB-α (∼37kDa), iNOS (∼135kDa)
and caspase-3 (cleaved caspase 3 (∼17kDa) was quantiﬁed
by densitometric scanning of the X-ray ﬁlms with GS-700
imaging densitometer (GS-700; Bio-Rad, Milan, Italy) and
a computer program (Molecular Analyst, IBM).
2.8. Materials. The primary antibodies directed at Bax
and Bcl-2 was obtained from Santa Cruz Biotechnology,
Inc. (Santa Cruz, CA, USA). The secondary antibody was
obtained from Jackson Immuno Research, Laboratories,
Inc. (Jackson, Bar Harbor, Maine, USA). Unless otherwise
stated, all compounds were obtained from Sigma-Aldrich
Company Ltd (Milan, Italy). All other chemicals were of the
highest commercial grade available. All stock solutions were
prepared in nonpyrogenic saline (0.9% NaCl; Baxter, Italy,
UK).
2.9. Data Analysis. All values in the Figures and text are
expressed as mean ± standard error of the mean of n
observations, where n represents the number of animals
studied. Data sets were examined by one-and two-way
analysis of variance and individual group means were then
compared with Bonferroni or Student’s unpaired t-test. A
P-value less than .05, was considered signiﬁcant. In the
experiments involving histology or immunohistochemistry,
theFigures shown arerepresentativeof atleast3 experiments
performed on diﬀerent experimental days.
3. Results
3.1. Eﬀect of WY14643 on Tissue Damage and Bone Resorp-
tion. When compared to gingivomucosal tissues sections
taken from the contra lateral side obtained from vehicle-
treated rats (Figure 1(a)), histological examination of gin-
givomucosaltissuessectionsofligature-operatedratsshowed
oedema, tissue injury as well as inﬁltration of the tis-
sue with inﬂammatory cells (Figure 1(b)). WY14643 treat-
ment reduced the degree of gingivomucosal tissues injury
(Figure 1(c)). Moreover Masson’s trichrome stain, which is
usedtomonitortheincreaseofcollagenﬁber,wasnegativein
gingivomucosal tissue sections taken from the contra lateral
side from vehicle when compared with gingivomucosal
tissues sections of ligature-operated rats (Figures 1(d) and
1(e), resp.). WY14643 treatment reduced the increase of
collagen (Figure 1(f)). In addition a radiographic examina-
tion of the mandibles, at eight day after ligature placement,
revealed bone matrix resorption in the lower left ﬁrst molar
region after ligation (Figure 1(g)). There was no evidence of
pathology in right ﬁrst molar (data not shown). WY14643
markedly reduced the degree of bone resorption in the lower
left ﬁrst molar region after ligation (Figure 1(h)).
3.2. Eﬀects of WY14643 Treatment on NF-κBA c t i v a t i o ni n
Periodontitis. We evaluated IκB-α degradation by Western
Blot analysis to investigate the cellular mechanisms by which
treatment with WY14643 may attenuate the development
of periodontitis. A basal level of IκB-α w a sd e t e c t e di nt h e
gingivomucosal tissues from the contralateral side obtained
from vehicle-treated rats, whereas in the gingivomucosal
tissues from ligature-operated rats IκB-α levels were sub-
stantially reduced (Figures 2aa n d2a1). WY14643 treatment
prevented the ligature induced IκB-α degradations in the
gingivomucosal tissues at eight days following ligation
(Figures 2aa n d2a1).
3.3. Eﬀect of WY14643 on Cytokines Expression. To test
whether WY14643 modulates the inﬂammatory process
through the regulation of secretion of proinﬂammatory
cytokines, we analyzed, by immunohistochemical analysis,4 PPAR Research
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Figure 1: Eﬀect of WY14643 on tissue damage and bone resorption. Gingivomucosal section from contra lateral side obtained from vehicle-
treated rats (a) demonstrating no tissue damage. Inﬂammatory cells inﬁltration and edema was observed in gingivomucosal section from
ligature-treated rats. (b) Signiﬁcantly less edema and inﬂammatory cells inﬁltration was observed in gingivomucosal section from ligature-
treated rats which have been treated with WY14643. (c) Moreover Masson’s trichrome stain was negative in gingivomucosal tissue sections
taken from the contra lateral side (d) from vehicle when compared with gingivomucosal tissues sections of ligature-operated rats. (e)
WY14643 treatment reduced the increase of collagen. (f) The alveolar bone from ligated rats demonstrated alveolar bone resorption. (g)
WY14643 treatment suppressed alveolar pathology in the rat alveolar bone. (h) Figure is representative of at least 3 experiments performed
on diﬀerent experimental days.
levels of TNF-α and IL-1β. Immunohistochemical analysis of
gingivomucosal tissues from the contra lateral side obtained
from vehicle-treated rats did not reveal any immunoreactiv-
ity for TNF-α and IL-1β (Figures 3(a) and 3(e),r e s p . ,s e e
densitometry D, H). In contrast, 8 days following ligation,
positive staining for TNF-α and IL-1β were found in the gin-
givomucosal tissues from ligature operated rats (Figures 3(b)
and 3(f), resp., see densitometry D, H). WY14643 treatment
signiﬁcantly reduced the degree of positive staining for these
proinﬂammatory cytokines TNF-α and IL-1β (Figures 3(c)
and 3(g), resp., see densitometry D, H).
3.4. Eﬀects of WY14643 on the Expression of Adhesion
Molecules (ICAM-1) and Neutrophils Inﬁltration in Peri-
odontitis. Immunohistochemical analysis of gingivomucosal
tissues from the contra lateral side obtained from vehicle-
treated rats did not reveal any immunoreactivity for ICAM-
1( Figure 4(a) see densitometry D). In contrast, 8 days
following ligation, positive staining for ICAM-1, was found
in the gingivomucosal tissues from ligature operated rats
(Figure 4(b) see densitometry D), mainly localized in the
inﬂammatory cells in derma and around the vessels. In
contrast, a positive staining for ICAM-1 was signiﬁcantlyPPAR Research 5
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Figure 2: Eﬀects of WY14643 treatment on NF-κB activation in
periodontitis. Representative Western blots showing the eﬀects of
WY14643 on IκB-α degradation (a, a1) in the gingivomucosal
tissues from ligature-operated rats. A representative blot of lysates
(a) obtained from 5 animals per group is shown and densitometry
analysis of all animals is reported. The results in panel (a1) are
expressed as mean ± s.e.m. from n = 5/6 gingivomucosal tissues
for each group.
∗P <. 01 versus nonligated.
◦P <. 01 versus ligated.
attenuated by the treatment with WY14643 (Figure 4(c)
see densitometry D). In addition myeloperoxidase activ-
ity was signiﬁcantly elevated at eight days after the lig-
ature (Figure 4(e)) and WY14643-treatment signiﬁcantly
reduced these levels (Figure 4(e)). No signiﬁcant changes
of myeloperoxidase activity were observed in the gingivo-
mucosal tissues from the contra lateral side obtained from
vehicle-treated rats (Figure 4(e)).
3.5. Eﬀects of WY14643 on iNOS Expression in Periodontitis.
Sections of gingivomucosal tissues from the contra lateral
side obtained from vehicle-treated rats did not reveal any
immunoreactivity for iNOS (Figure 5(a) see densitometry
D) within the normal architecture. At eight days following
ligation, a positive staining for iNOS (Figure 5(b) see
densitometry D) was found in the gingivomucosal tissues
from ligature-operated rats. WY14643 abolished the staining
for iNOS (Figure 5(c) see densitometry D). Furthermore,
ligature caused a signiﬁcant increase of iNOS expression,
assayed by Western blot analysis, in the gingivomucosal
tissues from ligature-operated rats compared to the gin-
givomucosal tissues from the contra lateral side obtained
from vehicle-treated rats (Figures 5ea n d5e1). A signiﬁcant
reduction of the iNOS levels was observed in the tissues from
WY14643 treated rats (Figures 5ea n d5e1).
3.6. Eﬀects of WY14643 on Nitrotyrosine Formation, and
Poly (ADP-Ribose) Polymerase Activation in Periodontitis.
Nitrotyrosine, a speciﬁc marker of NO-dependent oxidative
stress, was measured by immunohistochemical analysis in
thegingivomucosaltissuessectionstodeterminethelocaliza-
tion of “peroxynitrite formation” and/or other reactive nitro-
gen derivatives produced during experimental periodontitis.
Sections of gingivomucosal tissues from the contra lateral
side obtained from vehicle-treated rats did not reveal any
immunoreactivity for nitrotyrosine (Figure 6(a) see densit-
ometry H) within the normal architecture. At eight days
following ligation, a positive staining for nitrotyrosine was
found in the gingivomucosal tissues from ligature-operated
rats (Figure 6(b) see densitometry H). WY14643 treatment
abolished the staining for nitrotyrosine (Figure 6(c) see
densitometry H). Moreover, in our study, we have evaluated
formation of polymer of ADP-ribose (PAR), which is
synthesized by PAR polymerases (PARPs) from NAD (+). It
as an indicator of in vivo PARP activation and regulates cell-
survival and cell-death programmes. Immunohistochem-
istry for PAR, revealed the occurrence of positive staining
forPARinthegingivomucosaltissuesfromligature-operated
rats (Figure 6(f) see densitometry H). WY14643 treatment
reduced the degree of positive staining for PAR (Figure 6(g)
see densitometry H) in the in the gingivomucosal tissues.
Please note that no positive staining for PAR have been
found in gingivomucosal tissues section from the contra
lateral side obtained from vehicle-treated rats (Figure 6(e)
see densitometry H).
3.7. Eﬀects of WY14643 on Bax and Bcl-2 Expression. To test
whether PPAR-α gene plays a role on apoptosis in gingivo-
mucosal tissues after ligature placement, we measured Bax
and Bcl-2 expression by Immunohistochemical analysis at
eight days following ligation.
No positive staining for Bax was observed in gingivo-
mucosal tissues from the contra lateral side obtained from
vehicle-treated rats (Figure 7(a)). Immunohistochemistry
for Bax showed positive staining in the gingivomucosal
sections after ligature (Figure 7(b)). The degree of posi-
tive staining for Bax was markedly reduced in WY14643
(1mg/kg) treated rats (Figure 7(c)). To detect Bcl-2 expres-
sion, whole sample from gingivomucosal tissues of rats
were also analyzed by immunohistochemical analysis In
immunohistochemical assay the degree of positive staining
for Bcl-2 was markedly reduced in gingivomucosal sections
obtained after ligature (Figure 7(f)). The reduction of Bcl-
2 expression caused by ligature was signiﬁcantly attenu-
ated in gingivomucosal sections from WY14643treated rats
(Figure 7(g)).Anormalbasalstaining forBcl-2wasobserved
in gingivomucosal tissues from the contra lateral side
obtained from vehicle-treated rats (Figure 7(e)). Moreover
wehaveevaluated,bywesternblotanalysis,akeymediatorof
apoptosis belong to the asparate-speciﬁc cysteinyl proteases
or caspases. No cleaved caspase-3 expression was detectable6 PPAR Research
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Figure 3: Eﬀect of WY14643 on cytokines expression. Immunohistochemical analysis of gingivomucosal tissues from the contra lateral side
obtained from vehicle-treated rats did not reveal any immunoreactivity for TNF-α and IL-1β (a, e). Positive staining for for TNF-α and
IL-1β were found in the gingivomucosal tissues from ligature operated rats (b, f) after ligature. WY14643 treatment signiﬁcantly reduced the
degree of positive staining for TNF-α and IL-1β (c, g). Densitometry analysis of immunocytochemistry photographs (d, h); n = 5 photos
from each samples collected from all rats in each experimental group) for TNF-α and IL-1β from gingivomucosal tissue was assessed. The
assay was carried out by using Optilab Graftek software on a Macintosh personal computer (CPU G3-266). Densitometry data are expressed
as % of total tissue area.PPAR Research 7
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Figure 4: Eﬀects of WY14643 on the expression of ICAM-1 and neutrophils inﬁltration. Immunohistochemical analysis of gingivomucosal
tissues from the contra lateral side obtained from vehicle-treated rats did not reveal any immunoreactivity for ICAM-1. (a) Positive
staining for ICAM-1 was found in the gingivomucosal tissues from ligature operated rats. (b) In contrast, a positive staining for ICAM-
1 was signiﬁcantly attenuated by the treatment with WY14643. (c) Moreover myeloperoxidase activity (e) in gingivomucosal tissue was
signiﬁcantly increased by ligature compared to the contra lateral side obtained from vehicle-treated rats. WY14643 signiﬁcantly reduced
myeloperoxidase activity levels. Figure is representative of at least 3 experiments performed on diﬀerent experimental days. Densitometry
analysis of immunocytochemistry photographs; (d) n = 5 photos from each samples collected from all rats in each experimental group)
for ICAM-1 from gingivomucosal tissue was assessed. The assay was carried out by using Optilab Graftek software on a Macintosh personal
computer (CPU G3-266). Densitometry data are expressed as % of total tissue area. Data are means of mean ± s.e.m. from n = 10 rats for
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Figure 5: Eﬀect of WY14643 on iNOS expression. Sections of gingivomucosal tissues from the contra lateral side obtained from vehicle-
treated rats did not reveal any immunoreactivity for iNOS. (a) Positive staining for iNOS (b) was observed in gingivomucosal tissue
after ligature. In gingivomucosal tissue of WY14643 treated rats no positive staining was observed for iNOS. (c) Densitometry analysis
of immunocytochemistry photographs; ((d) n = 5 photos from each samples collected from all rats in each experimental group) for iNOS
from gingivomucosal tissue was assessed. The assay was carried out by using Optilab Graftek software on a Macintosh personal computer
(CPU G3-266). Densitometry data are expressed as % of total tissue area. Moreover, a signiﬁcant increase in iNOS expression (e, e1), assayed
by Western blot analysis, was detected in in gingivomucosal tissue after ligature. Treatment with WY14643 signiﬁcantly attenuated iNOS (e,
e1) expression in gingivomucosal tissue after ligature. A representative blot of lysates (e, e1) obtained from 5 animals per group is shown and
densitometry analysis of all animals is reported. Figure is representative of at least 3 experiments performed on diﬀerent experimental days.
∗P <. 01 versus nonligated.
◦P <. 01 versus ligated.PPAR Research 9
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Figure 6: Eﬀect of WY14643 on ligature-induced nitrotyrosine formation and PARP activation. No positive staining for nitrotyrosine was
observed in gingivomucosal tissues from the contra lateral side obtained from vehicle-treated rats. (a) Positive staining for nitrotyrosine (b)
was observed in gingivomucosal tissue after ligature. In gingivomucosal tissue of WY14643 treated rats no positive nitrotyrosine staining
was observed. (c) In addition, immunohistochemistry for PAR, an indicator of in vivo PARP activation, revealed the occurrence of positive
staining for PAR localized in gingivomucosal tissue after ligature. (f) WY14643 treatment reduced the degree of positive staining for PAR (g)
in the gingivomucosal tissue. No positive staining for PAR was observed in gingivomucosal tissues from the contra lateral side obtained from
vehicle-treatedrats(e).Densitometryanalysisofimmunocytochemistryphotographs((d,h);n = 5photosfromeachsamplescollectedfrom
all rats in each experimental group) for nitrotyrosine and PAR from gingivomucosal tissue was assessed. The assay was carried out by using
OptilabGrafteksoftwareonaMacintoshpersonalcomputer(CPUG3-266).Densitometrydataareexpressedas%oftotaltissuearea.Figure
is representative of at least 3 experiments performed on diﬀerent experimental days.
∗P <. 01 versus nonligated.
◦P <. 01 versus ligated.10 PPAR Research
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Figure 7: Eﬀects of WY14643 on Bax and Bcl-2 expression. No positive staining for Bax was observed in gingivomucosal tissues
from the contra lateral side obtained from vehicle-treated rats. (a) Immunohistochemistry for Bax showed positive staining in the
gingivomucosal sections after ligature. (b) The degree of positive staining for Bax was markedly reduced in WY14643 treated rats. (c)
In immunohistochemical assay the degree of positive staining for Bcl-2 was markedly reduced in gingivomucosal sections obtained
after ligature. (f) The reduction of Bcl-2 expression caused by ligature was signiﬁcantly attenuated in gingivomucosal sections from
WY14643treated rats. (g) A normal basal staining for Bcl-2 was observed in gingivomucosal tissues from the contra lateral side obtained
fromvehicle-treatedrats.(e)Densitometryanalysisofimmunocytochemistryphotographs((d,h);n = 5photosfromeachsamplescollected
from all rats in each experimental group) for Bax and Bcl-2 from gingivomucosal tissue was assessed. The assay was carried out by using
OptilabGrafteksoftwareonaMacintoshpersonalcomputer(CPUG3-266).Densitometrydataareexpressedas%oftotaltissuearea.Figure
is representative of at least 3 experiments performed on diﬀerent experimental days.
∗P <. 01 versus nonligated.
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Figure 8: Eﬀects of WY14643 on Cleaved caspase 3 levels. We have
evaluated, by western blot analysis, a key mediator of apoptosis
belong to the asparate-speciﬁc cysteinyl proteases or caspases. No
cleaved caspase 3 expression were detectable in the homogenized
gingivomucosal tissues from the contra lateral side obtained
from vehicle-treated rats (a, a1).Cleaved caspase 3 levels were
appreciably increased following ligation (a, a1). Treatment of rats
with WY14643 (1mg/kg) signiﬁcantly attenuated ligation-induced
of Cleaved caspase 3 levels (a, a1). A representative blot of lysates (a,
a1) obtained from 5 animals per group is shown and densitometry
analysis of all animals is reported. Figure is representative of at least
3 experiments performed on diﬀerent experimental days.
∗P <. 01
versus nonligated.
◦P <. 01 versus ligated.
in the homogenized gingivomucosal tissues from the contra
lateral side obtained from vehicle-treated rats (Figures 8a
and8a1).Cleavedcaspase-3levelswereappreciablyincreased
following ligation (Figures 8aa n d8a1). Treatment of rats
with WY14643 (1mg/kg) signiﬁcantly attenuated ligation-
induced of Cleaved caspase 3 levels (Figures 8a, a1).
4. Discussion
In this study, we demonstrate that a PPARα agonist,
WY14643, exerts beneﬁcial eﬀects in a rat model of
periodontitis. The treatment with WY14643 attenuates:
(1) Myeloperoxidase activity, (2) cytokines and adhesion
molecules expression, (3) NF-κB expression, (4) iNOS
expression, (5) the nitration of tyrosine residues (6) activa-
tion of the nuclear enzyme poly (ADP-ribose) polymerase,
(7) apoptosis (8) the degree of gingivomucosal tissues in
rats subjected to ligature-induced periodontitis. All of these
ﬁndings support the view that PPARα has a detrimental role
in the development of injury associated with periodontitis in
rats.IthasbeenknownthatPPARαagonistshaveantiinﬂam-
matory characteristics [15]. Although much is known about
gene activation by PPARs acting via PPREs, less information
exists about the mechanisms of negative gene modulation
by PPARs. Recently, PPARα have been suggested to exert
antiinﬂammatory activities interfering negatively with other
t r a n s c r i p t i o nf a c t o rp a t h w a y ss u c ha sN F - κB, signal trans-
ducers and activators of transcription (STAT), and activator
protein-1 (AP-1) [15]. PPAR-α increases IκBα expression,
thus preventing nuclear p50/p65 NF-κB translocation and
arrestingtheirnucleartranscriptionalactivity.Theseﬁndings
identify a molecular mechanism of negative gene regulation
by PPAR-α and reveal a direct implication for PPAR-α
in the modulation of the inﬂammatory gene response in
inﬂammation. In this work we demonstrate that the WY
14643 treatment inhibited IκB-α degradation in periodontal
tissue. NF-κB activation induces the transcription of many
proinﬂammatory genes, including nitric oxide synthase
expression (iNOS), TNF-α,I L - 1 β, and ICAM-1, to name but
af e w[ 16]. In precedent study we have demonstrated that,
in periodontitis, iNOS expression have a detrimental eﬀects
such us a cytotoxic action toward the host tissues, alveolar
bone resorption due to the stimulating eﬀect of nitric oxide
on the activity of the osteoclasts [12, 17]. In this study we
determined the expression, and thus the formation, of iNOS,
through the technique of immunohistochemistry. the same
technique was used to determine the localization of iNOS in
biopsies from patients with periodontitis [18]. Our results
demonstrate that WY 14643 treatment attenuates the expres-
sion of iNOS in periodontal tissue. During the initiation and
progression of periodontal disease, inﬂammatory cytokines
are considered to play important roles. Several reports
have suggested a relationship between the progression of
periodontitis and the expression of interleukin-1 (IL-1), IL-
6, IL-8 and tumour necrosis factor-α in gingival tissues [19].
We conﬁrm that the model of periodontitis used here leads
to a substantial increase in the levels of TNF-α and IL-
1β in the gingivomucosal tissue. Interestingly, the levels of
these two proinﬂammatory cytokines are signiﬁcantly lower
in the ligated-rats that were treated with WY 14643. In
addition, we also report in the present study that ligature-
induced periodontitis in the rat results in a signiﬁcant
inﬁltration of inﬂammatory cells in the gingivomucosal
tissues and we also demonstrated that treatment with
WY 14643 reduces this inﬂammatory cells inﬁltration as
assessed by myeloperoxidase and with the moderation of
the tissue damage as evaluated by histological examination.
A possible mechanism, by which WY 14643 attenuates
polymorphonuclear cells inﬁltration, is by downregulating
adhesion molecules ICAM-1 as demonstrated here [20].
These ﬁndings, therefore, suggest that exogenous PPAR-α
ligand reduced the activation and the subsequent expression
of proinﬂammatory genes. Activation and recruitment of
neutrophils and macrophages, in periodontitis, results in
the subsequently release mediators including reactive oxygen
species (ROS) [21] and nitric oxide (NO) [22]i n v o l v e di na
variety of inﬂammatory conditions [23, 24].12 PPAR Research
There are some evidences that NO inhibits neutrophil
migration by a mechanism dependent on the expression
of ICAM-1 on mesenteric microcirculation vessels of mice
subjected to experimental acute peritonitis by an injection
of either LPS, carrageenan (Cg), or (fMLP) [25]. In this
study, the authors treated the experimental peritonitis in
mice with chemical inhibitors for NO synthase (NOS) and
demonstrated an increase in the migration of neutrophils
into venular endothelium and enhanced the expression of
ICAM-1 on the endothelium. Interesting PPARγ agonists
suppressedneutrophilsmigrationinaNOexpressiondepen-
dent manner via iNOS which in turn suppress the ICAM-1
expression by endothelial cells [26]. Also, agonists for PPAR-
γ appear to amplify iNOS expression while they inhibit the
activationoftheinﬂammatorysignaltransductionmolecule,
NF-κB[ 27].
In our previous study we have just demonstrated that
aP P A R - γ agonist, as rosiglitazone, reduced the cellular
inﬁltration into the gingivomucosal tissue, in a experimental
model of periodontitis induced by ligature. A possible mech-
anism by which rosiglitazone attenuates polymorphonuclear
cell inﬁltration is by downregulating adhesion molecules
ICAM-1 and P-selectin expression in a NO dependent man-
ner [28]. Several studies also support the conclusion that NO
from iNOS plays an important role in the pathogenesis of
periodontitis [12]. Our ﬁnding of reduced iNOS expression
by rosiglitazone in vitro is also in accordance with our recent
reports clearly demonstrating that rosiglitazone inhibits the
expression of iNOS in another model of inﬂammation.
Thus, we also demonstrated in previous study such as in
experimental model a inﬂammatory bowel disease [29], that
PPAR-α agonist was able to reduce neutrophil inﬁltration in
a NO expression dependent manner via iNOS.
Several studies have implicated the role of ROS and
reactivenitrogenspeciesintissuedestructionassociatedwith
inﬂammatory periodontal diseases [30] via several mecha-
nisms including peroxidation of membrane lipids, protein
denaturation and DNA damage. To conﬁrm the pathological
contributionsofperoxynitritetotissuedamageafterligature,
we evaluated nitrotyrosine formation, an index of “increased
nitrosative stress” in the injured tissue. We observed that
the immunostaining for nitrotyrosine is reduced in rats
treated with WY 14643. ROS produce strand breaks in DNA
thattriggersenergy-consumingDNArepairmechanismsand
activatesthenuclearenzymePARPresultingintheactivation
of “the PARP Suicide Hypothesis”. There is recent evidence
that the activation of PARP may also play an important
role in experimental periodontitis [12, 31]. We demonstrate
here that WY 14643 attenuates the increase in PARP activity
in the periodontal tissue. Apoptosis, or programmed cell
death, is a form of physiological cell death. It is increased
or decreased in the presence of infection, inﬂammation
or tissue remodelling. Previous studies have suggested that
apoptosis is involved in the pathogenesis of inﬂammatory
periodontal disease [32]. It has also been demonstrated
that the higher frequency of Bcl-2 expression results in
progressive periodontal destruction [33]. As apoptosis is
an exceedingly complex process involving a large variety
of signalling molecules, we have focused our attention
on a few selective major players. From the results, we
identiﬁed proapoptotic transcriptional changes, including
up regulation of proapoptotic Bax and downregulation of
antiapoptotic Bcl-2, using a Western blot assay. This is
the ﬁrst study to show that treatment with WY 14643 in
periodontitis and prevents the loss of the antiapoptotic
pathway and, also, reduces activation of the proapoptotic
pathway by an, as yet, unidentiﬁed mechanism.
5. Conclusion
In conclusion, this study provides the ﬁrst evidence that
WY 14643 causes a substantial reduction of ligature-induced
periodontitis in the rat. The mechanisms underlying the
protective properties of WY14643 involve modulation of
transcriptionfactorsandconsequentalteredgeneexpression,
resulting in downregulation of inﬂammation. These ﬁndings
provide support that WY14643 may provide a promising
approach for the treatment of oxidative stress-related neu-
rodegenerative diseases.
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